« Previous
Next »
Cancer Letters
Volume 297, Issue 1
, Pages 84-90
, 1 November 2010
Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I – Thymidine kinase/ganciclovir in glioma
References
- . Prodrug-activating systems in suicide gene therapy. J. Clin. Invest. 2000;105:1161–1167
- . Current progress in suicide gene therapy for cancer. World J. Surg. 2002;26:783–789
- . Gene therapy for brain tumors. Curr. Oncol. Rep. 2000;2:463–472
- . Gene therapy scores against cancer. Nat. Med. 2000;6:862–863
- . Suicide gene therapy mediated by herpes simplex virus thymidine kinase gene/ganciclovir system: 15 years of application. Curr. Gene Ther. 2003;3:13–26
- . Guanosine analogues as anti-herpesvirus agents. Nucleos. Nucleot. Nucl. Acids. 2001;19:1531–1541
- . Acyclic/carbicyclic guanosine analogues as anti-herpesvirus agents. Nucleos. Nucleot. Nucl. Acids. 2001;20:271–285
- . The ‘bystander effect’: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 1993;53:5274–5283
- . Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 2000;60:3989–3999
- . Imaging transgene expression with radionuclide imaging technologies. Neoplasia. 2000;2:118–138
- . Reporter gene imaging: potential impact on therapy. Nucl. Med. Biol. 2005;32:763–780
- . Molecular-genetic imaging based on reporter gene expression. J. Nucl. Med. 2008;49:164S–179S
- . Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003;17:545–580
- . Applications of molecular imaging in cancer therapy. Curr. Gene Ther. 2005;59:607–618
- . Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J. Nucl. Med. 2002;43:1072–1083
- . Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J. Nucl. Med. 1998;39:2003–2011
- . Comparison of [14C]FMAU, [3H]FEAU, [14C]FIAU, and [3H]PCV for monitoring reporter gene expression of wild type and mutant herpes simplex virus type 1 thymidine kinase in cell culture. Mol. Imag. Biol. 2005;7:296–303
- . Comparison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs. stable transfection. Eur. J. Nucl. Med. Mol. Imag. 2003;30:1547–1560
- . Challenges in the design and conduct of phase III brain tumor therapy trials. Neurology. 1997;49:912–917
- . In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors. Science. 1992;256:1550–1552
- . Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors. Human Gene Ther. 1996;7:197–205
- . Gene therapy against an experimental glioma using adeno-associated virus vectors. Gene Ther. 1996;3:957–964
- . Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy. Human Gene Ther. 1997;8:2057–2068
- . Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol. Ther. 2000;1:195–203
- . Gene therapy for brain tumors: the fundamentals. Surg. Neurol. 2000;54:3–9
- . Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia. 2000;2:41–52
- . Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol. Ther. 2001;4:297–306
- . Non-invasive imaging for monitoring of viable cancer cells using dual-imaging reporter gene. J. Nucl. Med. 2004;45:2109–2115
- . A dual function fusion protein of herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant glioma. Genet. Vaccines Ther. 2004;2:7
- . Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet. 2001;9283:727–729
- . A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur. J. Nucl. Med. Mol. Imag. 2004;31:740–751
- . Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res. 2004;64:1323–1330
PII: S0304-3835(10)00252-1
doi: 10.1016/j.canlet.2010.04.028
© 2010 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Cancer Letters
Volume 297, Issue 1
, Pages 84-90
, 1 November 2010
